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a b s t r a c t
Klinefelter syndrome (KS), a 47,XXY chromosomal abnormality, has been shown to be associated with a
number of malignancies, but has not been linked to acute leukemias to date. We present a case of a 54-
year-old male diagnosed with acute myeloid leukemia (AML) with monocytic differentiation, whose
cytogenetic and subsequent FISH analyses revealed a constitutional 47,XXY karyotype. We also review
and discuss relevant prior literature.
& 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Klinefelter syndrome (KS), ﬁrst described in 1942, is character-
ized by male infertility, gynecomastia, and hypogonadism, and is
associated with the sex chromosome abnormality 47,XXY [1].
Patients with KS are known to be at an increased risk for developing
malignancy, including breast cancer, germ cell tumors, non-
Hodgkin lymphomas, and lung cancer [2]. Nevertheless, no clear
association between constitutional 47,XXY and acute leukemias has
yet been established [3]. We here report on a case of a patient with
constitutional 47,XXY and a diagnosis of acute myeloid leukemia
(AML), followed by a review of the relevant literature.
2. Case
A 54-year-old male with a medical history of non-insulin
dependent diabetes mellitus, hypertension, and gastroesophageal
reﬂux, initially presented to his dentist with left-sided gum pain.
Due to persistence of the pain, he was then evaluated by his
primary care physician, who noted a marked leukocytosis. He was
subsequently referred to the emergency room, where he was
found to have a white blood cell count (WBC) of 33,500/mm3, of
which 2% were blasts, a hematocrit of 22.2%, and a platelet count
of 131,000/mm3. He also had renal insufﬁciency, with a creatinine
of 1.74 mg/dL, and there was concern for tumor lysis syndrome,
with a uric acid of 10.1 mg/dL. On examination, he was obese and
appeared mildly uncomfortable. He was not hypoxic, and his heart
and lung examwere benign. Gynecomastia was present. He had no
family history of hematologic malignancy. He had one brother and
one sister, both of whom were reported to be healthy. He lived
with his wife and had no children. He previously worked in
construction, but was currently not working.
Given these abnormal laboratory results, a bone marrow biopsy
and aspirate were performed. The biopsy was hypercellular (95%
cellularity) and was replaced by sheets of blasts (Fig. 1A). On the
aspirate smear, there were 76% monoblasts (Fig. 1B), conﬁrmed by
ﬂow cytometric immunophenotyping. Bone marrow karyotype
was abnormal, with all metaphases (20 of 20) containing an
additional X chromosome as the sole aberration (Fig. 1C). Given
that a 47, XY, þX abnormality would be unusual for AML, a
monolayer culture of non-neoplastic bone marrow stromal cells
was studied to obtain a constitutional karyotype. Although no
metaphases were obtained from the monolayer culture, interphase
FISH analysis revealed that all scored nuclei contained two copies
of the X and one copy of the Y chromosome, conﬁrming that this
patient's constitutional karyotype was 47,XXY (Fig. 1D). Subse-
quent molecular genetic analysis revealed an NPM1 mutation at
exon 12, but no FLT3 or CEBPA mutations. The ﬁnal diagnosis was
acute myeloid leukemia with mutated NPM1.
The patient was hospitalized, treated for hyperuricemia, and
initiated on remission induction chemotherapy with cytarabine
and idarubicin (the “7þ3” regimen). His clinical course was
complicated by worsening tumor lysis, renal failure, volume over-
load, and pneumonia. He required hemodialysis, vasopressor
support, intubation, and mechanical ventilation for a period of
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approximately 10 days. His clinical status improved gradually, with
resolution of renal failure and pneumonia, and a mid-treatment
marrow biopsy at day 14 revealed an ablated marrow without
morphologic evidence of leukemia (less than 5% cellularity with no
increase in monoblasts). The remainder of his hospitalization was
complicated by Clostridium difﬁcile colitis, which was treated with
antibiotics. He experienced normal peripheral blood count recov-
ery and was discharged from the hospital in good condition.
A bone marrow biopsy subsequently conﬁrmed complete
remission 32 days after the start of induction therapy. Given the
relatively favorable prognostic risk associated with an isolated
NPM1 mutation, the patient has gone on to receive cycles of
consolidation chemotherapy with high dose cytarabine. He
remains in remission, now ﬁve months after his initial diagnosis.
3. Discussion
Cases of AML have been reported in patients with Klinefelter
syndrome since the 1960s [4], and there has been an interest in
investigating a potential association between a 47,XXY chromoso-
mal abnormality and myeloid malignancies. Certain constitutional
chromosomal abnormalities are known to be associated with
malignancy. For example, children with trisomy 21 (Down syn-
drome) have a 10–20 fold higher risk of developing acute leukemia
than other children [5]. Additional hematological malignancies
have been reported in patients with other constitutional chromo-
somal abnormalities (Table 1).
A 2002 review by Keung and colleagues summarized cases of
hematologic malignancy in patients with KS reported between
1961 and 2002 [3]. They described 12 cases of AML in KS in the
literature during that time period. Based on the review of the
current literature, we found approximately 10 additional cases of
AML in patients with constitutional 47,XXY. Overall, this is a rather
small number of reported cases over a period of greater than
5 decades, and studies to date have not deﬁnitively established an
epidemiological link [3,6].
Intriguingly, almost half the cases of AML with KS occurred in
the pediatric population (r18 years old at diagnosis) [3,7,8]. No
cases were diagnosed over the age of 64 [4,9,10]. This is note-
worthy given that the median age of AML at diagnosis is above 65,
and that the majority of AML cases are diagnosed in older patients.
These observations raise the question of whether KS, like certain
other constitutional abnormalities, may predispose to an earlier
onset of AML.
Additionally, in all but two cases in the reported literature, the
diagnosis of KS was made at the time of AML diagnosis. This would
suggest that an epidemiological association between the two
conditions may be overstated, as KS may be under-diagnosed in
the general population due to its range of phenotypic manifesta-
tion. Larger and more comprehensive studies would be needed to
study the possibility of an epidemiological link between AML and
Klinefelter syndrome, an association that may shed light on
disease genetics and mechanisms, and possibly further guide
monitoring and treatment in this population.
Authors' contributions
MMJ and ATF conceptualized the case, carried out the review
and analysis, and wrote the manuscript.
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Table 1
Reported congenital syndromes associated with hematological malignancies.
Congenital syndrome Associated hematological malignancy References
47,XXY (Klinefelter) AML, MDS, ALL [3,4,11]
45, XO (Turner) AML, T-LGL, CLL [12]
Trisomy 21 (Down) AML, ALL, TMD [13]
Trisomy 8 mosaicism MDS, ALL, IF [14,15]
TMD¼Transient Myeloproliferative Disorder.
T-LGL¼T-cell Large Granular Lymphocytic Leukemia.
IF¼ Idiopathic myeloﬁbrosis.
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